Australia's largest stock trading and investment forum Australia's #1 stock forum

ACTINOGEN MEDICAL LIMITED

3.45%

3.0¢

Market Cap $95.31M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

A new drug class and commercialisation for ACW

Latest Threads

Tag

Subject

ACW Chart Thread

3 4 5

21/04/25

263

107K

21/04/25

Last post Jimbob77

263

107K

Ann: ACW CMO presents Xanamem pTau poster at ADPD25 conference

02/04/25

0

567

02/04/25

Last post

ASX News

0

567

Ann: Actinogen presentation to ASX small & mid-caps conference

27/03/25

12

4.3K

27/03/25

Last post Stealth101

12

4.3K

Ann: ACW conducts Type C meeting with FDA regarding depression

27/03/25

0

650

27/03/25

Last post

ASX News

0

650

Ann: Appendix 3Ys x 5

24/03/25

0

368

24/03/25

Last post

ASX News

0

368

Ann: Notification of cessation of securities - ACW

24/03/25

0

253

24/03/25

Last post

ASX News

0

253

Ann: Notification of cessation of securities - ACW

24/03/25

0

249

24/03/25

Last post

ASX News

0

249

Ann: Application for quotation of securities - ACW

24/03/25

0

271

24/03/25

Last post

ASX News

0

271

Ann: Results of Meeting

14/03/25

0

500

14/03/25

Last post

ASX News

0

500

[INTERVIEW] A new drug class and commercialisation: what’s next for Actinogen?

06/03/25

44

14K

06/03/25

Last post Stealth101

44

14K

Ann: Notification of buy-back - ACW

04/03/25

8

2.9K

04/03/25

Last post Stealth101

8

2.9K

Ann: ACW HY25 results Advancing to latestage clinical development

25/02/25

7

4.4K

25/02/25

Last post Stealth101

7

4.4K

Ann: Actinogen HY2025 financial report and Appendix 4D

24/02/25

0

471

24/02/25

Last post

ASX News

0

471

2025 will be the year

2 3

23/02/25

176

63K

23/02/25

Last post lloydray

176

63K

Ann: Letter to Shareholders, Notice of GM & Proxy Form

10/02/25

0

776

10/02/25

Last post

ASX News

0

776

Ann: Peer-reviewed clinpharm manuscript published

08/02/25

21

6.9K

08/02/25

Last post dunover

21

6.9K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

ACW CMO presents Xanamem pTau poster at ADPD25 conference
02 Apr 12:28	Share

ACW conducts Type C meeting with FDA regarding depression
27 Mar 11:58	Share

Actinogen presentation to ASX small & mid-caps conference
26 Mar 11:06	Share

Appendix 3Ys x 5
24 Mar 16:58	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Application for quotation of securities - ACW
24 Mar 16:42	Share

Results of Meeting
14 Mar 10:35	Share

Notification of buy-back - ACW
04 Mar 16:56	Share

ACW HY25 results Advancing to latestage clinical development
24 Feb 15:28	Share

Actinogen HY2025 financial report and Appendix 4D
24 Feb 15:27	Share

Letter to Shareholders, Notice of GM & Proxy Form
10 Feb 13:28	Share

Peer-reviewed clinpharm manuscript published
06 Feb 13:34	Share

Application for quotation of securities - ACW
30 Jan 14:04	Share

ACW December 2024 quarterly activity report & Appendix 4C
29 Jan 08:58	Share

ACW presents at Sachs Neuro & WHO grants INN emestedastat
13 Jan 09:14	Share

Change in substantial holding
19 Dec 08:16	Share

Application for quotation of securities - ACW
16 Dec 17:04	Share

ACW to list $0.05 options exp 31 May 2027 - ASX code ACWOD
13 Dec 14:16	Share

Listed Options Top 20 & Distribution Schedule
13 Dec 14:15	Share

Application for quotation of securities - ACW
13 Dec 14:15	Share

ACW randomizes first US participant in Alzheimers trial
09 Dec 09:34	Share

Application for quotation of securities - ACW
05 Dec 14:28	Share

Notification of cessation of securities - ACW
03 Dec 10:55	Share

Notification of cessation of securities - ACW
28 Nov 16:22	Share

Results of Annual General Meeting
14 Nov 11:57	Share

Actinogen 2024 AGM, Chairs address and CEOs presentation
14 Nov 08:42	Share

Actinogen receives $9.0 million R&D tax incentive rebate
12 Nov 09:48	Share

Notification of buy-back - ACW
06 Nov 10:36	Share

Appendix 3Ys x 4
04 Nov 13:24	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.0¢		Change 0.001(3.45%)		Mkt cap ! $95.31M

Open	High	Low	Value	Volume
2.9¢	3.0¢	2.8¢	$32.51K	1.153M

Buyers (Bids)

No.	Vol.	Price($)
8	1180538	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	211059	3

View Market Depth

No.	Vol.	Price($)
8	1180538	0.027
8	1166300	0.026
20	2834187	0.025
8	3368783	0.024
6	683478	0.023

Price($)	Vol.	No.
0.030	211059	3
0.031	1631895	5
0.032	1782000	3
0.033	3931721	2
0.034	165000	2

Last trade - 16.10pm 21/04/2025 (20 minute delay)

ACW (ASX) Chart